Form 4: USANA Health Sciences Executive Chairman Kevin Guest Reports Acquisition of Restricted Stock Units

Kevin Guest, Executive Chairman of USANA Health Sciences, reports the acquisition of 31,425 restricted stock units on February 27, 2025.

Summary

• On February 27, 2025, Kevin Guest, the Executive Chairman of the Board at USANA Health Sciences, acquired 31,425 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of USNA common stock each.
• The restricted stock units vest at a rate of 25% on each subsequent February 27th.
• Following the reported transaction, Mr. Guest directly owns 75,423 shares of USNA common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of restricted stock units suggests confidence from the Executive Chairman in the company's future, but it's a standard executive compensation practice.

Positives

• The acquisition of restricted stock units by the Executive Chairman demonstrates confidence in the company's future performance.

Future Outlook

The restricted stock units vest over time, incentivizing the Executive Chairman to focus on long-term value creation for USANA Health Sciences.

Industry Context

This filing is a routine disclosure related to executive compensation and aligns with standard practices for publicly traded companies.

Stakeholder Impact

• The vesting of restricted stock units aligns the Executive Chairman's interests with those of the shareholders, incentivizing long-term value creation.

Key Dates